Mount Sinai Oncology will work with patients on a case by case basis to review insurance coverage. Patients can expect a call from the office after booking to discuss these details. The practice will try to accommodate the time selected however the appointment date and time may need to adjusted to better suit the specific patient case. Dr. Jeffrey Glassberg is currently an Assistant Professor of Emergency Medicine, Hematology and Medical Oncology at Mount Sinai School of Medicine. He obtained his MD and a Masters’ degree in clinical research at Washington University in St. Louis School of Medicine in 2006. Dr. Glassberg completed his emergency medicine residency at NYU/Bellevue in 2010, followed by a research fellowship at Mount Sinai in July of 2012. Currently, Dr. Glassberg is funded by the National Heart Lung and Blood Institute by a K23 career development award and also holds an appointment at Rockefeller University as a visiting scientist. Dr. Glassberg has become a leader in promoting evidence based strategies for the acute management of Sickle Cell Disease. He has several research focuses within Sickle Cell including pulmonary complications of Sickle Cell Disease, novel biomarkers for vaso-occlusive crises, and novel agents for the prevention and treatment of vaso-occlusion. In addition to practicing as an attending in the ED, Dr. Glassberg also sees patients in Sickle Cell clinic and serves as the primary physician for many patients with Sickle Cell disease who are at Mount Sinai. He is also active regionally and nationally as a member of the Queens Sickle Cell Advocacy Network, the New York Sickle Cell Advisory Council and the Sickle Cell Disease Association of America.

Education & experience

Education

Medical School - Washington University, St. Louis, Doctor of Medicine

Bellevue Hospital, Internship in Emergency Medicine

Bellevue Hospital, Residency in Emergency Medicine

Practice

Mount Sinai Cancer

Affiliation

The Mount Sinai Hospital

Certifications

American Board of Emergency Medicine

Professional memberships

Queens Sickle Cell Advocacy Network

New York Sickle Cell Advisory Council

Sickle Cell Disease Association of America

Awards and publications

Glassberg JA, Strunk R, DeBaun MR. Wheezing in children with sickle cell disease. Current opinion in pediatrics 2014 Feb; 26(1).

Glassberg JA, Tanabe P, Chow A, Harper K, Haywood C, DeBaun MR, Richardson LD. Emergency provider analgesic practices and attitudes toward patients with sickle cell disease. Annals of emergency medicine 2013 Oct; 62(4).

Glassberg J, Simon J, Patel N, Jeong JM, McNamee JJ, Yu G. Derivation and preliminary validation of a risk score to predict 30-day ED revisits for sickle cell pain. The American journal of emergency medicine 2015 Oct; 33(10).

Perry M, Simon J, Gareau D, Glassberg J. Bayesian analyses demonstrate tissue blood volume is not decreased during acute sickle cell pain episodes: A preliminary study. Clinical hemorheology and microcirculation 2015 Jan;.

Glassberg J, Spivey JF, Strunk R, Boslaugh S, DeBaun MR. Painful episodes in children with sickle cell disease and asthma are temporally associated with respiratory symptoms. Journal of pediatric hematology/oncology 2006 Aug; 28(8).